﻿<?xml version="1.0" encoding="UTF-8"?>
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>Nickan Research Institute</PublisherName>
      <JournalTitle>Journal of Renal Endocrinology</JournalTitle>
      <Issn>2423-6438</Issn>
      <Volume>4</Volume>
      <Issue>1</Issue>
      <PubDate PubStatus="ppublish">
        <Year>2018</Year>
        <Month>01</Month>
        <DAY>01</DAY>
      </PubDate>
    </Journal>
    <ArticleTitle>PTH abnormalities in chronic kidney disease</ArticleTitle>
    <FirstPage>e01</FirstPage>
    <LastPage>e01</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Mitra</FirstName>
        <LastName>Naseri</LastName>
      </Author>
    </AuthorList>
    <PublicationType>EDITORIAL</PublicationType>
    <ArticleIdList>
      <ArticleId IdType="doi">
      </ArticleId>
    </ArticleIdList>
    <History>
      <PubDate PubStatus="received">
        <Year>2017</Year>
        <Month>05</Month>
        <Day>04</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2017</Year>
        <Month>06</Month>
        <Day>19</Day>
      </PubDate>
    </History>
    <Abstract>Implication for health policy/practice/research/medical education Conservative treatments for improving altered calcium–phosphorous hemostasis in dialysis patients and also dialysis modalities may inverse PTH abnormalities from hyper to hypoparathyroidism, an abnormality which needs completely different management.</Abstract>
    <ObjectList>
      <Object Type="keyword">
        <Param Name="value">Fibroblast growth factor-23</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Chronic kidney disease</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Parathyroid hormone</Param>
      </Object>
    </ObjectList>
  </Article>
</ArticleSet>